Reaktionsgleichung
NC1(C2C=CC(C3C(=O)C4C(=CC=C(F)C=4)OC=3C3C=CC=CC=3)=CC=2)CCC1.C(OC(=O)[NH:36][C:37]1([C:41]2[CH:46]=[CH:45][C:44]([C:47]3[C:56](=[O:57])[C:55]4[C:50](=[CH:51][C:52]([C:58]5[NH:59][N:60]=[CH:61][CH:62]=5)=[CH:53][CH:54]=4)[O:49][C:48]=3[C:63]3[CH:68]=[CH:67][CH:66]=[CH:65][CH:64]=3)=[CH:43][CH:42]=2)[CH2:40][CH2:39][CH2:38]1)(C)(C)C>>[NH2:36][C:37]1([C:41]2[CH:42]=[CH:43][C:44]([C:47]3[C:56](=[O:57])[C:55]4[C:50](=[CH:51][C:52]([C:58]5[NH:59][N:60]=[CH:61][CH:62]=5)=[CH:53][CH:54]=4)[O:49][C:48]=3[C:63]3[CH:68]=[CH:67][CH:66]=[CH:65][CH:64]=3)=[CH:45][CH:46]=2)[CH2:40][CH2:39][CH2:38]1Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
Following the procedure used to prepare 3-[4-(1-amino-cyclobutyl)-phenyl]-6-fluoro-2-phenyl-chromen-4-one, (1-{-4-[4-oxo-2-phenyl-7-(2H-pyrazol-3-yl)-4H-chromen-3-yl]-phenyl}-cyclobutyl)-carbamic acid tert-butyl ester was reacted to give the title compound as a cream solid (27 mg, 92%). 1H NMR (400 MHz, DMSO-d6): δ 13.36-13.12 (br s, 1H), 8.14-8.11 (m, 2H), 8.05-8.00 (m, 1H), 7.90-7.83 (br s, 1H), 7.48-7.33 (m, 7H), 7.21-7.17 (m, 2H), 7.00 (d, J=3 Hz, 1H), 2.47-2.39 (m, 2H), 2.24-2.15 (m, 2H), 2.08-1.97 (m, 1H), 1.73-1.64 (m, 1H). LCMS (Method F): RT=8.99 min, [M+H]+=434.
Aufarbeitung
- customwas reacted
Quellen und Nachweise
- ORD-Eintrag
- ord-b13327ecf6854dac99f45e2c4085d23a
- Quelldatensatz
- uspto-grants-2013_10
- Patentnummer
- US08546376B2
Verknüpfte Notizen
Wird geladen…